Councils - Pulmonary Hypertension
| SCIENTIFIC COUNCIL ON PULMONARY HYPERTENSION | | COUNCIL LEADERSHIP | QUICK LINKS | |
| 
Mayo Clinic
Rochester, Minnesota, USA
507-284-0294
frantz.robert@mayo.edu
Robert P. Frantz, MD, FACC, is Director of the Pulmonary Hypertension Clinic at the Mayo Clinic in Rochester, Minnesota, and Associate Professor of Medicine at the College of Medicine, Mayo Clinic. Primary interests include pulmonary hypertension both WHO Group I, and also associated with left heart disease and in context of MCS and transplantation. He performs hemodynamic assessments including exercise and drug interventions in the catheterization laboratory for patients with PAH, left heart disease, and MCS. Clinical responsibilities include management of cardiac transplant candidates and recipients, PAH, advanced left heart disease, and MCS recipients. Dr. Frantz graduated cum laude (Biochemistry) from Harvard University, Cambridge MA. He received his medical degree from Mayo Medical School, Rochester MN and completed Internal Medicine residency at the Mayo Graduate School of Medicine. After completing fellowship in Cardiovascular Diseases at University of Rochester Medical Center, Strong Memorial Hospital, Rochester, NY, Dr. Frantz joined the staff of the Mayo Clinic in 1990. Dr. Frantz is board certified in cardiology and internal medicine.
University of Chicago
Chicago, Illinois, USA
773-702-5589
mgomberg@medicine.bsd.uchicago.edu
Mardi Gomberg-Maitland, MD, MSc, is Associate Professor of Medicine and Director of the Pulmonary Hypertension Program at the University of Chicago Medical Center. She is an expert clinician and researcher in the field of pulmonary heart disease. In recent years, she has participated in dozens of multi-center, multi-national research trials to explore new therapies for pulmonary hypertension. She is a former Doris Duke Clinical Scientist winner for her research in Phase I drug development. She is currently focusing on pulmonary arterial, pulmonary venous hypertension/diastolic dysfunction, and biomarker development. Dr. Gomberg-Maitland attended medical school at the Albert Einstein College of Medicine in New York. She completed her residency at the New York Presbyterian Hospital-Weill/Cornell Medical Center and a fellowship at Mount Sinai Medical Center in New York. In addition, she has earned a Masters in Clinical Epidemiology from Harvard School of Public Health in Boston, Massachusetts. She is board certified in Internal Medicine and Cardiology.
University of Maryland School of Medicine
Baltimore, Maryland, USA
410-328-7260
mpark@medicine.umaryland.edu
Myung Park, MD, FACC, is Director of the Pulmonary Vascular Diseases Program & CCU, and Associate Professor of Medicine, at the University of Maryland Medical Center. After receiving her medical degree from the Temple University School of Medicine, Dr. Park continued her training in Philadelphia with an internship and residency in internal medicine at Temple University Hospital.This was followed by a fellowship in cardiovascular medicine at the Medical College of Virginia. She furthered her training by completing an advanced fellowship in Heart Failure and Cardiac Transplantation at the Cleveland Clinic Foundation. Dr. Park is board certified in cardiology and internal medicine. She specializes in pulmonary hypertension, heart transplantation, advanced heart failure, and ventricular assist devices. | | | 
Freeman Hospital
Newcastle University & CT Centre
Newcastle Upon Tyne, UNITED KINGDOM
44-191-223-1084
paul.corris@ncl.ac.uk
Bio coming soon...
Toronto
General Hospital
Toronto, Ontario,
CANADA
416-340-5549
Marc.DePerrot@uhn.ca
Bio
coming soon....
Brigham & Women's Hospital
Boston, MA, USA
617-732-8535
mmehra@partners.org
Dr. Mehra, an internationally recognized cardiologist with expertise in the treatment of heart failure and heart muscle damage, cardiac transplantation and mechanical circulatory devices, is professor of Medicine at Harvard Medical School and Executive Director of the Center for Advanced Heart Disease at the Brigham and Women's Hospital in Boston, MA (USA). He obtained his cardiovascular training at the Ochsner Clinic Foundation, where he sub-specialized in the field of advanced heart failure and cardiac transplantation. He is board certified in internal medicine and cardiovascular diseases. His specific research interests in cardiac transplantation focus on post-transplant coronary arterial disease, new immunosuppressive therapy to improve heart transplant outcomes, and bringing genomic and proteomic science (the study of protein interactions in the body) to the bedside. In the field of heart failure, his research has focused on the role of new devices and novel serum markers to guide diagnosis and therapy.
University of Maryland School of Medicine
Baltimore, MD, USA
410-328-7260
mpark@medicine.umaryland.edu
See 'Past Chair' for bio.
UT Southwestern Medical Center
Dallas, Texas, USA
214-645-5989
fernando.torres@utsouthwestern.edu
Bio coming soon... | | 
Weill Cornell Medical Center
New York, New York, USA
212-746-2381
horneve@med.cornell.edu
Dr. Evelyn Horn is the Director of Heart Failure and Pulmonary Hypertension at the Perkin Heart Failure Center of Weill Cornell, specializing in Heart Failure, Pulmonary Hypertension, and Mechanical Circulatory Support. She is a graduate of Brown University, Mount Sinai Medical School where she also was a medical intern and resident. She completed cardiology at the Cedars Sinai/UCLA program and thereafter spent 2 years as a research fellow at Columbia College of Physicians and Surgeons, understanding the beta adrenergic G protein complex in heart failure, the denervated heart and models of arrhythmias. She has received numerous awards as clinician educator and continues to participate in clinical research in the areas of cardiac and vascular remodeling in heart failure and pulmonary hypertension. | | 
Kaiser San Francisco
San Francisco, California, USA
415-710-9935
Dana.p.McGlothlin@kp.org
Bio coming soon... | | 
University of Toronto
Toronto, Ontario, CANADA
416-340-4485
john.granton@uhn.on.ca
Bio coming soon... | | 
Johns Hopkins University
Baltimore, Maryland, USA
410-614-6311
smathai4@jhmi.edu
Bio coming soon...
Vanderbilt University Medical Center
Nashville, Tennessee, USA
615-322-6512
ivan.robbins@vanderbilt.edu
Bio coming soon... | | 
University of California, San Francisco
San Francisco, California, USA
415-476-3117
demarco@medicine.ucsf.edu
Bio coming soon...
| | |
University of Maryland School of Medicine
Baltimore, MD, USA
410-328-7260
mpark@medicine.umaryland.edu
See bio under "Past Chair". | | 
Vanderbilt University Medical Center
Nashville, Tennessee, USA
615-343-0895
j.west@vanderbilt.edu
Dr. West’s research focuses on early molecular events in the etiology of heritable pulmonary arterial hypertension, and whether these events are applicable to the broader field of idiopathic pulmonary arterial hypertension. His work uses several transgenic and nontransgenic mouse models, cell culture, and patient samples. His group is currently studying the role of BMPR2 and CAV1 mutations in altering focal adhesions and cytoskeletal defects, intracellular trafficking (and steroid hormone trafficking in particular), metabolism and generation of reactive oxygen species, and interaction between pulmonary vascular cells and circulating inflammatory cells. Dr. West has also just assumed responsibility for the Pulmonary Hypertension Breakthrough Initiative lung collection at Vanderbilt. | | 
Ohio State University
Columbus, Ohio, USA
614-293-4967
veronica.franco@osumc.edu
Bio coming soon... |
|
|
